Sort   by:  
 Page size 
UnknownThe effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studies.
Not available
S-EPMC11027824 | biostudies-literature
UnknownImmune-Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Synopsis of Response Rates.
Not available
S-EPMC8265367 | biostudies-literature
UnknownRadiotherapy Improves Survival in NSCLC After Oligoprogression on Immunotherapy: A Cohort Study.
Not available
S-EPMC11490415 | biostudies-literature
UnknownImmune Checkpoint Inhibitors +/- Chemotherapy for Patients With NSCLC and Brain Metastases: A Systematic Review and Network Meta-Analysis.
Not available
S-EPMC11753865 | biostudies-literature
UnknownSmall-Cell Lung Cancer-An Update on Targeted and Immunotherapies.
Not available
S-EPMC10179261 | biostudies-literature
UnknownPhase 1a dose escalation study of ivonescimab (AK112/SMT112), an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors.
Not available
S-EPMC11033648 | biostudies-literature
UnknownEvaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers: Subgroup Analysis of a Phase 2 Nonrandomized Clinical Trial.
Not available
S-EPMC7393585 | biostudies-literature
UnknownThe Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma.
Not available
S-EPMC6313363 | biostudies-literature
UnknownSite-Specific Response and Resistance Patterns in Patients with Advanced Non-Small-Cell Lung Cancer Treated with First-Line Systemic Therapy.
Not available
S-EPMC11172392 | biostudies-literature
UnknownUse of durvalumab in stage III non-small-cell lung cancer based on eligibility for the PACIFIC study.
Not available
S-EPMC9968599 | biostudies-literature
Sort   by:  
 Page size